Report cover image

Industrial Fasteners Market

Published Jan 08, 2026
Length 68 Pages
SKU # GV20873127

Description

Industrial Fasteners Market Summary

The global industrial fasteners market size was estimated at USD 103.92 billion in 2025 and is projected to reach USD 153.71 billion by 2033, growing at a CAGR of 5.1% from 2026 to 2033. The market is expected to be driven by the growing population, high investments in the construction sector, and rising demand for industrial fasteners in the automotive and aerospace sectors.

Infrastructure development is one of the key parameters to consider when tracking the regional market development. The construction industry notably impacts the demand for industrial fasteners as they are extensively used in buildings, bridges, walls, and roofs. Unlike other industries, fasteners used in construction are standardized and subject to stringent quality checks. Government intervention through a regulatory framework pressurizes manufacturers to offer standardized products with superior performance characteristics. The U.S. is one of the largest fastener-importing countries in the world and is likely to witness a similar trend over the forecast period on account of high product demand in automation, aerospace, and other industrial applications. Moreover, owing to the growing demand for lightweight vehicles and aircraft, companies are shifting from standard to customized products, which in turn is positively increasing the U.S. fastener market size across these industries.

The market for industrial fasteners is characterized by intensive technological developments to produce advanced, lightweight products that find usage in automotive and other industrial applications. With the enhancement in technology, the rising demand for hybrid fasteners, which incorporate a combination of injection-molded plastic components with metal elements, is expected to drive the demand.

Increasing metal prices and the decelerating growth of these fasteners, owing to their replacement by plastic fasteners, automotive tapes, and adhesives, are expected to be key barriers for metal fastener manufacturers over the forecast period. Plastic fastener manufacturers are expected to gain an advantage owing to the rising demand for lightweight components from automotive manufacturers.

Companies engaged in the manufacturing of fasteners require significant capital investment owing to the high production volumes and stringent specifications concerning testing and labeling. Industrial fasteners, including bolts, screws, nuts, studs, and rivets, are manufactured and distributed by various participants. Companies invest significantly in R&D activities, thus resulting in dynamic market conditions.

Global Industrial Fasteners Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global industrial fasteners market report based on raw material, product, application, distribution channel, type, and region.
  • Raw Material Outlook (Revenue, USD Million, 2021 - 2033)
  • Metal fasteners
  • Plastic Fasteners
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Externally Threaded Fasteners
  • Internally Threaded Fasteners
  • Non-threaded Threaded Fasteners
  • Aerospace Grade Fasteners
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Automotive
  • Aerospace
  • Building & Construction
  • Industrial Machinery
  • Home appliances
  • Lawns and gardens
  • Motors and pumps
  • Furniture
  • Plumbing products
  • Other Applications
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Direct
  • Indirect
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Bolts
  • Screws
  • Nuts
  • Washers
  • Rivets
  • Other Types
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • Spain
  • France
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Malaysia
  • Indonesia
  • Thailand
  • Central & South America
  • Brazil
  • Middle East & Africa
  • Saudi Arabia
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

68 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. Product
1.2.3. End Use
1.2.4. Application
1.2.5. Regional Scope
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights
Chapter 3. Infectious Respiratory Disease Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. High Prevalence Of Infectious Respiratory Diseases Globally
3.2.1.2. Technological Advancement In Respiratory Disease Testing
3.2.1.3. Rising R&D Investments In Respiratory Disease Testing
3.2.2. Market Restraint Analysis
3.2.2.1. High Prices Of Diagnostic Products
3.2.2.2. Presence Of Ambiguous Regulatory Framework
3.3. Infectious Respiratory Disease Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
Chapter 4. Infectious Respiratory Disease Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Infectious Respiratory Disease Diagnostics Market: Product Movement Analysis
4.3. Infectious Respiratory Disease Diagnostics Market by Product Outlook (USD Million)
4.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
4.5. Instruments
4.5.1. Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.6. Reagents
4.6.1. Reagents Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.7. Services
4.7.1. Services Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Infectious Respiratory Disease Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Infectious Respiratory Disease Diagnostics Market: Technology Movement Analysis
5.3. Infectious Respiratory Disease Diagnostics Market by Technology Outlook (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
5.5. Immunoassay
5.5.1. Immunoassay Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Molecular Diagnostics
5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Microbiology
5.7.1. Microbiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Rapid/Point-of-Care Diagnostics
5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.9. Other Technologies
5.9.1. Other Technologies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Infectious Respiratory Disease Diagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Infectious Respiratory Disease Diagnostics Market: Application Movement Analysis
6.3. Infectious Respiratory Disease Diagnostics Market by Application Outlook (USD Million)
6.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
6.5. COVID-19
6.5.1. COVID-19 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Influenza
6.6.1. Influenza Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Respiratory Syncytial Virus
6.7.1. Respiratory Syncytial Virus Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Tuberculosis
6.8.1. Tuberculosis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.9. Non-tuberculosis Mycobacterium Testing
6.9.1. Non-tuberculosis Mycobacterium Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.10. Bacterial Pneumonia Testing
6.10.1. Bacterial Pneumonia Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.11. Other Respiratory Disease Testing
6.11.1. Other Respiratory Disease Testing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Infectious Respiratory Disease Diagnostics Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Infectious Respiratory Disease Diagnostics Market: End Use Movement Analysis
7.3. Infectious Respiratory Disease Diagnostics Market by End Use Outlook (USD Million)
7.4. Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the following
7.5. Hospitals
7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Diagnostic Laboratories
7.6.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Research Institutes
7.7.1. Research Institutes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8. Clinics
7.8.1. Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Infectious Respiratory Disease Diagnostics Market: Regional Estimates & Trend Analysis
8.1. Regional Dashboard
8.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
8.3. North America
8.3.1. U.S.
8.3.1.1. Key country dynamics
8.3.1.2. Regulatory framework/ reimbursement structure
8.3.1.3. Competitive scenario
8.3.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
8.3.2. Canada
8.3.2.1. Key country dynamics
8.3.2.2. Regulatory framework/ reimbursement structure
8.3.2.3. Competitive scenario
8.3.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
8.3.3. Mexico
8.3.3.1. Key country dynamics
8.3.3.2. Regulatory framework/ reimbursement structure
8.3.3.3. Competitive scenario
8.3.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework/ reimbursement structure
8.4.1.3. Competitive scenario
8.4.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
8.4.2. Germany
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework/ reimbursement structure
8.4.2.3. Competitive scenario
8.4.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
8.4.3. France
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework/ reimbursement structure
8.4.3.3. Competitive scenario
8.4.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
8.4.4. Italy
8.4.4.1. Key country dynamics
8.4.4.2. Regulatory framework/ reimbursement structure
8.4.4.3. Competitive scenario
8.4.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
8.4.5. Spain
8.4.5.1. Key country dynamics
8.4.5.2. Regulatory framework/ reimbursement structure
8.4.5.3. Competitive scenario
8.4.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
8.4.6. Norway
8.4.6.1. Key country dynamics
8.4.6.2. Regulatory framework/ reimbursement structure
8.4.6.3. Competitive scenario
8.4.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
8.4.7. Sweden
8.4.7.1. Key country dynamics
8.4.7.2. Regulatory framework/ reimbursement structure
8.4.7.3. Competitive scenario
8.4.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
8.4.8. Denmark
8.4.8.1. Key country dynamics
8.4.8.2. Regulatory framework/ reimbursement structure
8.4.8.3. Competitive scenario
8.4.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework/ reimbursement structure
8.5.1.3. Competitive scenario
8.5.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
8.5.2. China
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework/ reimbursement structure
8.5.2.3. Competitive scenario
8.5.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
8.5.3. India
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework/ reimbursement structure
8.5.3.3. Competitive scenario
8.5.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
8.5.4. Australia
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework/ reimbursement structure
8.5.4.3. Competitive scenario
8.5.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
8.5.5. South Korea
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework/ reimbursement structure
8.5.5.3. Competitive scenario
8.5.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
8.5.6. Thailand
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework/ reimbursement structure
8.5.6.3. Competitive scenario
8.5.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework/ reimbursement structure
8.6.1.3. Competitive scenario
8.6.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
8.6.2. Argentina
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework/ reimbursement structure
8.6.2.3. Competitive scenario
8.6.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework/ reimbursement structure
8.7.1.3. Competitive scenario
8.7.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework/ reimbursement structure
8.7.2.3. Competitive scenario
8.7.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
8.7.3. UAE
8.7.3.1. Key country dynamics
8.7.3.2. Regulatory framework/ reimbursement structure
8.7.3.3. Competitive scenario
8.7.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
8.7.4. Kuwait
8.7.4.1. Key country dynamics
8.7.4.2. Regulatory framework/ reimbursement structure
8.7.4.3. Competitive scenario
8.7.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Recent Developments & Impact Analysis by Key Market Participants
9.3. Company Market Share Analysis, 2025
9.4. Key Company Profiles
9.4.1. ABBOTT
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. F. Hoffmann - La Roche Ltd
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. BD
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. KONINKLIJKE PHILIPS N.V.
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. BIOMÉRIEUX SA
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. BIO-RAD LABORATORIES, INC.
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. QUIDEL CORPORATION
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. CEPHEID
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. QIAGEN
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. SIEMENS HEALTHCARE GMBH
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
9.4.11. Seegene Inc.
9.4.11.1. Company overview
9.4.11.2. Financial performance
9.4.11.3. Product benchmarking
9.4.11.4. Strategic initiatives
9.4.12. EliTechGroup (Bruker Corporation)
9.4.12.1. Company overview
9.4.12.2. Financial performance
9.4.12.3. Product benchmarking
9.4.12.4. Strategic initiatives
9.4.13. CERTEST BIOTEC
9.4.13.1. Company overview
9.4.13.2. Financial performance
9.4.13.3. Product benchmarking
9.4.13.4. Strategic initiatives
9.4.14. Thermo Fisher Scientific, Inc.
9.4.14.1. Company overview
9.4.14.2. Financial performance
9.4.14.3. Product benchmarking
9.4.14.4. Strategic initiatives 
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.